Showing results (2001-2010 of 4,518) with videos related to

Sort By:
Pageof 452
Advances in Therapy|February 27, 2015
The cost of thromboembolic events in hospitalized patients with breast or prostate cancer in FranceFlorian Scotte, Nicolas Martelli, Alexandre Vainchtock, et al.
Advances in Therapy|February 19, 2015
IPF Care: a support program for patients with idiopathic pulmonary fibrosis treated with pirfenidone in EuropeAnnette Duck, Lucy Pigram, Peter Errhalt, et al.
Advances in Therapy|March 4, 2015
Measles in Morocco: epidemiological profile and impact of vaccination strategyAmine Cheikh, Mouncif Ziani, Zakia Cheikh, et al.
Advances in Therapy|March 11, 2015
Cost-effectiveness analysis of mometasone furoate versus beclomethasone dipropionate for the treatment of pediatric allergic rhinitis in ColombiaCarlos E Rodríguez-Martínez, Monica P Sossa-Briceño, Elkin Vladimir Lemos
Advances in Therapy|March 17, 2015
Nomenclature and traceability debate for biosimilars: small-molecule surrogates lend support for distinguishable nonproprietary namesJingdong Chao, Martha Skup, Emily Alexander, et al.
Advances in Therapy|July 11, 2020
Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT StudyMaggie Tabberer, C Elaine Jones, Sally Kilbride, et al.
Advances in Therapy|July 11, 2020
Economic Evaluation of Cisplatin Plus Gemcitabine Versus Paclitaxel Plus Gemcitabine for the Treatment of First-Line Advanced Metastatic Triple-Negative Breast Cancer in China: Using Markov Model and Partitioned Survival ModelMingjun Rui, Fenghao Shi, Ye Shang, et al.
Advances in Therapy|February 22, 2015
A randomized, crossover study to investigate the pharmacokinetics and safety of inhaled fluticasone furoate and umeclidinium, administered separately and in combination via dry powder inhaler in healthy adult volunteersShuying Yang, Laurie Lee, Stephen Mallett, et al.
Advances in Therapy|February 22, 2015
Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label studyA E Bagriy, E V Schukina, O V Samoilova, et al.
Advances in Therapy|July 24, 2012
Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patientsHiroko Mori, Yosuke Okada, Tadashi Arao, et al.
Pageof 452